Evaluatio N of a Pi X Aban in STR O Ke and Systemic Embolism Prevention in Patients With Non‐valvular Atrial Fibrillation in Clinical Practice S Etting in France, Rationale and Design of the NAXOS: SNIIRAM Study

Clinical Cardiology - United States
doi 10.1002/clc.23231
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

Primary and Secondary Prevention of Stroke and Systemic Embolism With Rivaroxaban in Patients With Non-Valvular Atrial Fibrillation

Heart and Vessels
Cardiovascular MedicineCardiology
2018English

Pcv42 - A Pharmacoeconomic Analysis of the Use of Apixaban for the Prevention of Stroke and Systemic Embolism in Russian Patients With Non-Valvular Atrial Fibrillation

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Clinical Characteristics and 12-Month Outcomes of Patients With Valvular and Non-Valvular Atrial Fibrillation in Kenya

PLoS ONE
Multidisciplinary
2017English

Cost-Effectiveness of Rivaroxaban for the Prevention of Stroke in Patients With Non-Valvular Atrial Fibrillation – A Multinational Study

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2013English

PCV7 a Mixed Treatment Comparison (MTC) to Compare the Efficacy of Anti-Thrombotic Agents in the Prevention of Stroke and Systemic Embolism (SE) in Patients With Non-Valvular Atrial Fibrillation (NVAF)

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2012English

Noncentral Nervous System Systemic Embolism in Patients With Atrial Fibrillation

Circulation. Cardiovascular quality and outcomes
MedicineCardiovascular MedicineCardiology
2017English

Pcv75 - An Updated Cost-Effectiveness Pairwise Analysis of Apixaban and Warfarin for Stroke Prevention in Patients With Non- Valvular Atrial Fibrillation in France

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Study Design and Baseline Characteristics of the EXPAND Study: Evaluation of Effectiveness and Safety of Xa Inhibitor, Rivaroxaban for the Prevention of Stroke and Systemic Embolism in a Nationwide Cohort of Japanese Patients Diagnosed as Non-Valvular Atrial Fibrillation

Tohoku Journal of Experimental Medicine
BiochemistryMedicineGeneticsMolecular Biology
2016English

Clinical Analysis of Antithrombotic Treatment and Occurrence of Stroke in Elderly Patients With Non-Valvular Persistent Atrial Fibrillation

Clinical Cardiology
MedicineCardiovascular MedicineCardiology
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy